Skip to main content
. 2014 Mar 17;9(3):e91388. doi: 10.1371/journal.pone.0091388

Figure 2. Kaplan-Meier analyses of overall survival (OS), progression-free survival (PFS), distant metastasis-free survival (DMFS) and local-regional control (LRC) according to the microRNA signature in the training data set (42 SCLC patients).

Figure 2